19 April 2016 - Deborah Wilkes
Archived
Boehringer Ingelheim said worldwide sales by its Consumer Health Care business increased by 7.1% on a currency-adjusted basis to EUR1.51 billion (US$1.72 billion) in 2015. The rise at the OTC business, which could soon be owned by Sanofi, was 5.3% as reported.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.